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Summary. The k-FGF gene, which belongs to the family 
of the fibroblast growth factor genes, is implicated in 
tumoral and developmental processes. It is expressed in 
embryonal carcinoma cells, in embryonic stem cells, 
during limb and tooth formation and in some germ cell 
tumors. However, the expression of this protooncogene 
during testicular development as well its relationship to 
spontaneous teratogenesis have not been determined. 
Here we investigate k-FGF expression during testicular 
development in mice, as well as in a spontaneous 
testicular teratoma (STT) and in the OTT6050 
teratocarcinoma (TC) by Northern blotting, RT-PCR and 
in situ hybridization. Severa1 data indicate that k-FGF 
gene contains downstream regulatory sequences which 
bind octamer factors. One of these transcription factors 
which binds to k-FGF enhancer is Oct-4. Although the 
k-FGF gene is activated by Oct-4 in embryonal 
carcinoma and embryonic stem cells and Oct-4 is 
expressed in the germ cells of the embryo, our results 
indicate that there is no detectable k-FGF expression in 
mouse testicular germ cells at any stage of development. 
This indicates that Oct-4 does not activate transcription 
of the k-FGF gene in mouse germ cells, and that k-FGF 
is not implicated during testicular development. We also 
show that there is a high k-FGF expression in the 
experimental OTT6050 TC, but only very low levels in a 
murine differentiated STT, suggesting that k-FGF 
activation may be responsible for the genesis and 
development of STT, behaving as a marker of 
malignancy in these neoplasms . 
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(Delli Bovi and Basilico, 1987) or FGF-4 (Hébert et al., 
1990) is a member of the fibroblast growth factor (FGF) 
family of genes. This family includes nine members 
classified more or sequence comparisons than on 
functional equivalente (Burgess and Maciag, 1989; 
Tronick and Aaronson, 1995). FGFs are implicated in 
cell proliferation, cell differentiation, morphogenesis and 
neoplasia. They are mitogenic for cells derived from 
mesoderm and neuroectoderm lineages. The product of 
the k-FGF gene is a secreted glycoprotein of 22-kD that 
stimulates the proliferation of NIH 3T3 fibroblasts (Delli 
Bovi et d . ,  1987) as well as HUE vascular endotheliai 
cells (Miyagawa et al., 1988; Yoshida et al., 1994), 
demonstrating a role for k-FGF in angiogenesis. In 
addition, the role of k-FGF in development has been 
demonstrated in Xenopus laevis by its mesoderm- 
inducing capacity of ectodermal tissue explants (Paterno 
et al., 1989) as well in the mouse. In mice, k-FGF is 
expressed in peri-implantation embryos (Rappolee et al., 
1994), is essential for postimplantation mouse 
development (Feldman et al., 1995), and also 
participates in myogenesis and in specific epithelial- 
mesenchymal interactions during limb and tooth 
morphogenesis (Nisswander and Martin, 1992; 
Niswander et al., 1993, 1994; Vogel and Tickle, 1993; 
Jernvall et al., 1994). Al1 these data suggest that FGFs in 
general, and particularly k-FGF, have different roles in 
normal development. On the other hand, k-FGF gene is 
implicated in the tumoral process. It was isolated after 
transfection of human stomach cancer DNA (Sakamoto 
et al., 1986) and from Kaposi sarcoma DNA (Delli Bovi 
et al., 1987) which contained DNA rearrangements 
upstrearn and downstream of the coding sequences. 
Due to the fact that the proteins encoded in the 
oncogene and in the protoncogene are identical (Yoshida 
et al., 1987; Delli Bovi et al., 1988), the oncogenic 
activation of the k-FGF gene must result from 
unregulated expression and not from the genesis of a 
mutated form. Transfection of its cDNA induces cell 
motility, and malignancy (Delli Bovi et al., 1988; 
McLeskey et al. ,  1993; Taylor et  al., 1993). It is 
expressed in human testicular germ cell tumors 
(Schofield et al., 1991; Strohmeyer et al., 1991) and in 
teratocarcinoma stem cells (Velcich et al. ,  1989; 
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#~ht&d 8t d., 1991). In addiiion, it is faund amplified 
(Chikuba et al., 1995) and coamplified with the int-2 
gene (Yoshida et al., 1988a-d) and the bcl-I gene 
(Volling et al., 1993) in some human cancers, and there 
is an association between amplification, high k-FGF 
expression and metastatic phenotype in mouse mammary 
tumors (Murakami et al., 1990) and in an experimental 
system (Damen et al., 1991). Moreover, angiogenic 
properties of the k-FGF oncogene have also been 
determined, and its possible association with the 
metastatic phenotype (Brustle et al., 1992; Díaz-Flores et 
al., 1994). 
An aspect that has not been studied is its expression 
during testicular development in mice. Testicular 
development involves cell migration, proliferation and 
differentiation processes. During embryogenesis, small 
amounts of primordial germ cells (PGC) are clustered 
around the hind gut of E7.5. They proliferate, move into 
the wall of the hind gut, leave the gut through the dorsal 
mesentery and travel around the dorsal aorta and the 
coelomic angles into the genital ridges. PGC reach 
genital ridges at 10.5-1 1.5 days postcoitum @.c.), the 
place where the future gonad will be formed. Sexual 
differentiation starts at 12.5 days p.c.. In male embryos, 
the number of PGC increases steadily until days 14-16 
p.c., as soon as the testis cords are formed (this depends 
on the strain of mice) and then are arrested in the G1 
phase of the cell cycle (Kluin and de Rooij, 198 1). 
During the postnatal period spermatogenesis starts. After 
birth, gonocytes proliferate and give rise to A 
spermatogonia (Vergouwen et al ., 199 1 ), then the 
numbers of stem cell spermatogonia and the production 
of differentiating spermatogonia increase almost twofold 
between day 13 and week 12 (Kluin et al., 1984). In 
male mice, meiotic division does not start until 
9-10 days post partum (p.p.) and spermiogenesis 
approximately until30 days p.p. 
In addition to al1 these data, testicular tumors, 
particularly nonseminomas, express high levels of k- 
FGF mRNA (Strohmeyer et al., 1991). Neither adult 
testis nor any somatic cell express k-FGF (Burgess and 
'Maciag, 1989). It is also known that k-FGF expression 
in undifferentiated embryonal carcinoma (EC) and 
embryonic stem (ES) cells is controlled by an upstream 
NF-Y-binding site, and a downstream element residing 
in the third exon which functions as an enhancer 
(Curatola and Basilico, 1990; Sasaki et al., 1991; Hasan 
et al., 1994; Koda et al., 1994; Bryans et al., 1995). 
These regulatory elements include a consensus octamer 
sequence that is a target for positive regulation by Oct-4 
(Schoorlemmer and Kmijer, 1991). Due to the fact that 
k-FGF is positively regulated by Oct-4, that Oct-4 is 
expressed in PGC (Scholer et al., 1989; Scholer, 1991) 
and that k-FGF is expressed in EC cells and ES (Yoshida 
et al., 1988b; Heath et al., 1989; Velcich et al., 1989; 
Hébert et al., 1990) and in germ cell testicular tumors, 
we decided to study k-FGF expression during testicular 
development in mice. We investigated k-FGF expression 
in developing gonads from mouse embryos, in mouse 
postnatal testis, in the experimental OTT6050 terato- 
carcinoma (TC) and in a spontaneous testicular teratoma 
(STT) by Northern blotting, RT-PCR and in  situ 
hybridization. 
Materials and methods 
Testis, tumor and embryo obtention 
Postnatal testis at different stages of development 
were obtained from 1291Sv male mice. 1291sSv isogenic 
mice were obtained from Prof. Jacob of the Pasteur 
Institute (Paris, France). Day of partum was designed as 
TO. T2, T5, T10, T18, T25 and T72 testis were dissected 
and extracted from the intraperitoneal cavity of male 
1291Sv mice. 
O'TT6050 mouse TC used in these experiments was 
obtained by injecting subcutaneously lo5 embryoid 
bodies (EB) in PBS into 129ISv isogenic mice, and 
dissecting the tumor after 2 weeks. OTT6050 TC was 
derived from 1291Sv mouse E6.5 grafted to a histo- 
compatible host testis. The ascitic form of the tumor 
(EB) was obtained after severa1 intraperitoneal passages 
of solid TC (Stevens, 1970). EB were kindly supplied by 
Prof. Jacob. A STT was obtained from an adult 1291Sv 
mouse left testis. 
Embryos were obtained from pregnant 129ISv 
isogenic mice. 129ISv mice have been maintained in our 
laboratory since 1984. Noon of the day on which the 
copulating plug was observed was considered to be 0.5 
days of gestation (E0.5). Embryos at early post- 
implantation stages (E7.5 to E9.5) were processed 
including decidua, E10.5 to E1 1.5 were dissected from 
the implantation site and processed including extra- 
embryonic annexes and E1 2.5 to E14.5 were dissected 
from decidua and annexes. For Northern blot and RT- 
PCR analysis, the head and the body were dissected 
(below the liver) in E13.5 to E14.5. 
Cell culture 
F9 embryonal carcinoma cell line was cultured in 
gelatin-coated petri dishes in Dulbecco's Modification of 
Eagle's Medium (DMEM) (Flow Lab.) containing 10% 
fetal calf serum (FCS) (Serva) and 1% L-Glutamine. 
Cells were cultured at 37 "C in a 5% C02 atmosphere to 
confluence. They were disrupted in a solution containing 
0.25% trypsin and 0.04% EDTA and washed in PBS. 
RNA and DNA isolation 
Total cellular RNA was isolated by the acid 
guanidinium thiocyanate-phenol-chloroform extraction 
method (Chomzynski and Sacchi, 1987). 
DNA from F9 cells was isolated by the method 
described by Blin and Stafford (1976). 
Primer design 
For specific priming in RT-PCR analysis, two 20nt 
oligonucletide primers spanning the second intron of the 
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mouse k-FGF gene (Brookes et al., 1989), RTKF2 
S'TGGTGAGCATCTTCGGAGTG 5' and RTKFl 5' 
TTCATGGTAGGCGACACTCG 3' were designed and 
produced in a DNA synthesizer (Applied Biosystems). 
RT- PCR reaction 
For the reverse transcriptase reaction, 100 ng of 
RNA samples were heated at 95 "C for 10 min, cooled 
on ice and cDNA synthesis was performed at 42 "C for 
30 min in 50mM KCI, lOmM Tris-HC1 pH 9.0, 0.1% 
Triton X-100, 1.5mM MgC12 using 1mM dNTPs 
(Pharmacia), 20 U RNasin (Promega), 100 pmoles 
downstream primer (RTKFl) and 10 U AMV reverse 
transcriptase (Promega). Then the reaction mixture was 
heated at 95 "C for 10 min, chilled on ice and 100 
pmoles upstream primer (RTKF2) and 1 U AmpTaq 
DNA pol (Perkin Elmer Cetus) were added for a normal 
PCR reaction. The thermal profile used was 95 "C 
denaturation for 1 min, annealing of primers at 68 "C for 
1 min and extension of the primers at 72 "C for 1 min. 
This cycle was repeated 22 times. 
Southern blotting 
One tenth of the RT-PCR reaction was fractioned in 
a 1.8% agarose TBE gel, stained with ethidium bromide, 
photographed, treated with 0.25N HCl, 1M NaCYO.5M 
NaOH, equilibrated in 0.5M Tris-HCI pH 7.411.5M NaCl 
and blotted to Genescreen membranes (Dupont) in 
10xSSC. DNA was imrnobilized by baking the 
membrane at 80 "C. Hybridization was performed in 
50% formamide, 6xSSPE, 1 % SDS, 50 pglml denatured 
salmon sperm DNA at 42 "C for 16 to 24 h. A Aval1 155 
pb mouse genornic k-FGF fragment including 3rd 
coding exon and 2nd intron sequences was used as a 
probe. This probe recognized k-FGF-specific genomic 
and RNA-amplified fragments, but not priming 
sequences. This was labelled to a specific activity of 
2x106 cpmlml using a random primer DNA Labeling kit 
(Boehringer Mannheim) and a 3 2 ~ - d ~ ~ ~  (Amersham). 
After hybridization, filters were washed and exposed to 
XAR films (Kodak) at -80 "C using intensifying screens, 
and developed. 
RNA probes and Northern blotting 
A mouse 417 bp HindllIXbal fragment from 
pXMT2-1.58kFGF plasmid that included the 2nd exon 
and a part of intronic sequences, was subcloned in 
pBluescript 11 SK + (Stratagene) giving rise to 
pBSkfHX. pBSkfHX was linealized with Hindll and 
Xbal. a 3 2 ~ - ~ ~ ~  and a 3 2 ~ - ~ ~ ~  labelled single stranded 
antisense and sense k-FGF riboprobes were transcribed 
using T3 and T7 RNA pol res ectively. 
As a positive control. a aq2P-UTP labelled human B- 
actin cRNA was used as a probe. The human B-actin 
cDNA cloned in pGEM4Z (Promega) was linealized 
with EcoRI and Hindlll before being transcribed using 
T7 RNA pol and SP6 RNA pol to create antisense and 
sense single-stranded ridoprobes. Both were alkaline 
hydrolized to reduce probes to an average size of 400 nt. 
For Northern blotting experiments, 25 p g  of total 
RNA were denatured in 50% formamide, 2.2M 
formaldehyde, 20mM MOPS pH 7.0, 5mM sodium 
acetate, and lmM EDTA. RNA samples were diluted in 
loading buffer containing 0.1 % bromophenol blue and 
10% glycerol and electrophoresed in 1% agarose- 
formaldehyde-MOPS gel. The gel was transferred onto 
Genescreen membranes (Dupont) in 10xSSC. 
Hybridization was performed in 50% formamide, 5x 
Denhardt's solution, SxSSPE, 1% SDS, 200 pglml 
denatured, and fragmented salmon sperm DNA at 42 "C 
for 16 to 24 h. 
Riboprobes were used at a specific activity of 2x10~  
cpmlml. Washes were made at  high stringency 
conditions and autoradiography was performed as 
Southern blots. For B-actin hybridization, k-FGF 
riboprobe was removed from the filter by washing in 
50% formamide, 6xSSPE for 40 min at 65 "C. 
In situ hybridization 
Testis, tumors and embryos were fixed in 4% 
paraformaldehyde, 5mM MgC12 in PBS, dehydrated, 
embedded in paraffin wax and sectioned at 6 pm. In situ 
hybridization conditions were performed at high 
stringency conditions according to the method of 
Frohman et al. (1990). k-FGF and B-actin riboprobes 
were used at a specific activity of lo5 cpmtpl. Slides 
were exposed to an autorradiographic emulsion (NTB2, 
Kodak) 1: 1 diluted in 0.6M ammonium acetate at 4 "C in 
the dark between three to four weeks (k-FGF) or one 
week (human B-actin) before being developed and 
stained with hematoxylin-eosin. 
Results 
Northern blot analysis of kFGF mRNA in postnatal testis, 
0776050 TC, a 129/Sv STT, F9 cells and embryos I 
It is known that murine gonocytes and testicular 
germ cells prepared from neonatal mice proliferation in 
vitro. Due to the fact that k-FGF mRNA is expressed in 
human and murine embryonal carcinoma cells, mouse 
embryonic stem cells and human testicular germ cell 
tumors, we investigated the expression of the k-FGF 
gene in postnatal testis at different days postpartum (T2, 
T5, T10, T14, T25 and T72) by Northern blotting. As 
shown in Fig. 1 there was no detectable expression in 
I 
mouse testis at different ages of development. 
We also analyzed k-FGF expression in a STT, in the 
OTTóO50TC and in F9 cells. We were unable to &tect 
any transcript (Fig. l),  even after exposing the X ray 1 
film for several days in S R .  In O'iT6050 TC and in F9 
cells we detected a transcript of 3.5 kb, although the 
leve1 of expression was severa1 fold higher in F9 cells 
(Fig. 1). Finally, we could not detect any k-FGF 
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Flg. 1. Northern bbt anatysis of RNA samples from F9 cells (lane l ) ,  OTT6050 TC (lane 2), 129/Sv STT (lane 3), testls of 2,5, 10, 14,25 and 72 days 
p.c. (lanes 4 to 9) and mwse embryos of 7.5 to 12 days (lanes 10 to 15) and head of 13.lday and 14.5day embryos (lanes 16 and 18) and body of 
13.5 days and 14.5-day embryos (lanes 17 and 19). 25 yg of total RNA are electrophoresed in each line. A aP32-UTP-labelled antisense k-FGF 
nboprobe is used, as desdbed in matenals and meíhods. Film was expooed overnight. The same membrane was reprobed with the antisense human 
O-adin níprobe. 
Fig. 2. RT-PCR analysis of k-FGF transcripts. Ethidium bromide-stained agarose gel of reverse transcriptase-polymerase chain reaction (RT-PCR) 
products (A). 100bp ladder (lane l ) ,  F9 DNA (lane 2), RNA from F9 cells (lane 3). from OTT6050 teratocarcinoma (lane 4), from a spontaneous 
testicular teratoma (lane 5), from 2, 5, 10, 14, 25 and 72 days p.p. testis (lanes 6 lo l l ) ,  from 7.5-, 8.5-, 9.5-, 10.5-, 11.5-. 12.5-day mouse embryos 
(lanes 12 to 17), from heads of 13.5- and 14.5-day embryos (lanes 18 and 20) and from bodies of 13.5- and 14.5-day embryos (lanes 19 and 21). 
Southern blot of the same gel, using as a probe a aJ2P-dCTP-labelled 155 bp Avall fragment (see material and methods) (B). The positions of 
molecular weight markers are indicated. 
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transcript in postimplantation mouse embryos (E7.5 to 
E12.5 and from head and body of E13.5 to E14.5) on 
Northem blots under our experimental conditions (Fig. 
1). 
These results showed that k-FGF rnRNA expression 
was apparently restricted to undifferentiated F9 cells and 
OTT6050 TC, being undetectable in testis, STT and 
embryos under our experimental conditions. However, 
the possibility that expression was restricted to few 
clumps of cells of the testis and of the S'IT, which could 
not be detected by this technique, was not ruled out. 
RT-PCR analysis of postnatal testis, a 129/Sv STT, 
077-6050 TC, F9 cells and embryos 
Amplification of RNA-specific sequences via cDNA 
(RT-PCR) is a powerful and very sensitive method to 
analyze RNA (Kawasaki et al., 1988). Due to the fact 
that we could not detect k-FGF mRNA in postnatal 
testis, STT or embryos, we decided to analyze the 
presence of k-FGF transcripts by RT-PCR. The analysis 
of the PCR products revealed (Fig. 2) a 249 bp visible 
band on the agarose gel and a strong signal onto the blot 
corresponding to the specific prirned RNAs in F9 cells 
and OTT6050 TC. We also detected a clearly visible 
fragment in postimplantation mouse ernbryos and only a 
faint band in the STT on the blot. However, we did not 
observe appreciable expression in T2 testis. As a control 
of k-FGF-specific priming 500 ng of F9 DNA was used, 
detecting a band of 649 bp as expected (Fig. 2). 
In situ hybridizafion in testis, fumors and embryo sections 
Using testis sections of different postnatal ages (T2, 
Fig. 3. Bright field (A) and dark field photograph (B) of OlT6050 TC hybridized wRh a a32P-UTP-labelled antisense k-FGF riboprobe. Embryonal 
carcinoma (EC) cells express high amounts of k-FGF transcripts. x 250 
Fig. 4. Bright field (A) and dark field 
photograph (E) of a 7.5-day mouse embryo 
hybridized with a a32P-UTP-labelled anti- 
sense k-FGF riboprobe. Arrows indicate k- 
FGF transcription in the primitive streak 
x 250 
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B, no, m, ?gl) and bybri&Pbg wíth &e antisense k- 
H3P'ribpmbe, we cwld not &tect any expression, even 
a;Ber e x p i n g  the slides for one month, as expected 
'tíie m I @  a M  in RT-KX experiments (data 
a@ s h ) .  Qn ttre o k r  hmd, in Sl'T sections, where 
we mdd not observe tk p m n c e  of undrfferentiated 
EC calle, we did not detsct remarkable Ir-FGF 
expmsim in m y  dlffenxtthted t h u e  (data not shown). 
Hm&ver, and in t with h m h  obtained by 
BT"-FCR, we d e t e ~ t d  k-F@F expre%~*sian i EC cells 
aitbin ik OTTWm TC (Fig. 3), differentiated cells 
being c m p k b l y  negative. Bn &e other hand, in mouse 
embryo &ons we detwted expmsion in the primitive 
s$ealr of E75 (Fig. 4), but we were unhle to detect any 
s p B c  e x p s i o n  in the ckve1oping mowe gonad (Fig. 
5).  
Sections were hybridized with an antisense human 
B-actin riboprobe, giving a high signal in al1 the cells 
w m  hybridiized with 
u s i q  the same 
e x p a d ,  we did 
l b  k-FOP 
et al. (1!3%9), i9 
of the fibroblwt geowth factor family that has bean 
inwobcí ra mU plihration ourd diff~fekltisrtion during 
ear1y QBvzyl-nt. In tdctíiam to its roke In the normal 
d e w : l ~ w ,  it has begn h p l i a t e d  21 the h~moral, as 
mentimd &ave. Tbrefwre, E-FGF exprmsion has 
bean studied nainly  in many turnors and during 
embryogenesis. However, k-FGF expression has not 
been studied during testicular development. Testicular 
germ cells prepared from mwtai (48 h after birth) mice 
proliferate in vino (Maekawa and Nishimune, 191) and 
there is a high proliferative activity of gomqms ín tha 
pre- (day 14 postcoitutn) and early po"stmtd periBd (day 
2 postpartum) of murine testicular development 
(Vergouwen et al., 1991), effects with presumably are 
the consequence of the action of a different GFs. Severa1 
GFs play different roles during testicular development. 
Insulin or IGF-1 is required during the initial phase of 
testicular organization (Taketo et al., 1991) and nerve 
growth factor-like proteins with mitogenic activity have 
been isolated from round spermatids and pachytene 
spermatocytes (Onoda et al., 1991). In particular, a basic 
fibroblast growth factor has been detected in immature 
and adult testis (Mayerhofer et al., 1991; Lahr et al., 
1992). 
Although k-FGF is not expressed in any adult tissue, 
including adult testis (Yoshida et al., 1988a-c), previous 
data have shown that a great number of human testicular 
germ cell tumors express the k-FGF protoncogene 
(Strohmeyer et al., 1991). However, we have not 
detected k-FGF expression by Northern blotting (Fig. l),  
in situ hybridization (data not shown) or even by the 
very sensitive RT-PCR method, at any stage of testicular 
development (Fig. 2). There is not very much 
information about factors that regulate K-FGF gene 
during embryogenesis. However, recent evidence 
suggests that k-FGF expression is regulated by a NK-Y 
transcription factor that binds to k-FGF promoter (Hasan 
et al., 1994; Bryans et al., 1995) and several ubiquitous 
as well as cell-specific octamer factors that bind to k- 
FGF enhancer (Koda et al., 1994). One of the factors 
that can control its expression is the product of Oct-4 
gene, also known as Oct-3 or NF-A3. Although it is 
known that Oct-4 is expressed in PGC of embryo testis, 
but not in the sperm of adult testis (Scholer, 1991) and 
that this factor activates k-FGF transcription in 
undifferentiated EC and ES cells (Schoorlemmer and 
Kruijer, 1991), it clearly does not do so in immature 
male germ cells. The cause of this lack of expression is 
not clear; one possibility might be that in these cells Oct- 
4 is neither necessary nor sufficient for the regulation of 
k-FGF expression. The other possibility could be that 
6. bk'i (A) md derk.fW -gph @$ ed ri 14.[j-dBy i'imm embryo dewbpfng testis section hybridlzed wíth a aaP-UTP-labelled 
antiseiwrek-K3fribopFobe.~onswen, b I c e m u ~ f o r 3 ~ a t 4 O C . x 2 5 0  
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after birth, with the appearance of the A spermatogonia 
and the onset of spermatogenesis, Oct-4 was 
downregulated, k-FGF transcription not being activated. 
It should be noted that Oct-4 is a target for negative 
regulation by retinoic acid (RA) (Okamoto et al., 1990), 
which in tum mediates its action through RA receptors. 
Vanbeek and Meistrich (1992) reported the irnportance 
of retinoic acid in the maintenance of spermatogenesis. 
Therefore, it should be of interest to analyze RA and RA 
receptor expression in mouse testis after birth and in 
early spermatogenesis (prepubertal stage). 
In a spontaneous, 1291Sv mouse testicular teratoma 
(STI'), we did not detect appreciable k-FGF expression 
by Northem blotting, although we detected a faint band 
after blotting the products of the RT-PCR reaction and 
hybridizing with a specific probe (Fig. 2). This fact 
indicates that probably only some small groups of un- 
differentiated cells, which were not included in the 
analyzed STT sections, express k-FGF, reflecting the 
conversion to benignancy of the tumor. This clearly 
associates k-FGF with the degree of undifferentiation of 
this tumor. Supporting this idea, k-FGF is expressed in 
primary human testicular tumors (Yoshida et al., 1988a- 
d; Schofield et al., 1991 ; Strohmeyer et al., 1991). 
We used the experimental OTT6050 TC as a positive 
control for k-FGF expression. We detected expression in 
the stem cells of the tumor (EC cells), but not in the 
differentiated tissue by in situ hybridization. The fact 
that k-FGF is expressed in the stem cells of the tumor 
and that it is known that this GF acts via an autocrine 
mechanism (Delli Bovi et al., 1988; Talarico and 
Basilico, 1991; Moscatelli, 1994), suggest a role of k- 
FGF in O'IT6050 TC in vivo growth. 
By Northern blot analysis, we also detected a 
different level of expression between the nullipotent F9 
cell line and the multipotent OTT6050 TC. This result is 
not surprising and may be explained because OTI'6050 
TC contained some differentiated cells which are known 
not to express k-FGF, and also because there are 
differences in the level of k-FGF expression between 
several EC cell lines, as previously demonstrated by 
Schoorlemmer and Kruijer (1991). 
In agreement with the results previously reported by 
Niswander and Martin (1992) indicating k-FGF 
expression during gastnilation, myogenesis and limb and 
tooth development, we detected k-FGF transcripts in 
mouse embryos from E7.5 to E12.5 (Figs. 2, 4) and in 
the head and body of E1 3.5 and E14.5 (Fig. 2) by RT- 
PCR. Using an antisense riboprobe for the k-FGF gene, 
we confirmed some of these results by detecting k-FGF 
expression in the dista1 part of the primitive streak of 
E7.5 (Fig. 4). This zone of the primitive streak contains 
cells that are fated to become embryonic, but not 
extraembryonic mesoderm. As discussed by Niswander 
and Martin (1992), this finding suggests that k-FGF is 
involved in the specification of some cells within the 
streak as well as in mesoderm induction in mammals, as 
demonstrated in amphibia by Paterno et al. (1989). In 
E7.5, the base of the allantosis, the area where PGC are 
located, is completely negative, indicating that PGC do 
not express the k-FGF gene. This result is surprising, 
because k-FGF is directly transactivated by Oct-4, which 
is known to be expressed in PGC and in the mouse 
gonad (Scholer, 199 1). However, some evidence 
suggests that there may be an interaction between Oct-4 
and an ElA-like factor. One could speculate that Oct-4 
could be complexed by an E1A-like factor, avoiding it 
binding to the k-FGF enhancer. Indeed, E1A acts as a 
bridging factor for transcriptional.regulation by Oct-4 
(Scholer et al., 1991). Another possibility for this lack of 
k-FGF expression in PGC could be addressed to the 
presence of a transcriptional repressor. This lack of k- 
FGF expression in the developing gonad was also 
maintained in later stages (E12.5, E13.5 and E14.5 
mouse embryo sections). 
These results indicate that although k-FGF gene is 
not involved in mouse testicular development, it is 
involved in mesodermal induction and in the growth of 
the experimental OTT6050 TC. At the same time, the 
detection of very low levels of k-FGF transcription in 
STI', its absence in differentiated cells of STT, as well as 
its expression in undifferentiated OTT6050 TC cells 
suggest that the activation of this gene is probably 
related to the genesis and progression of STI'. 
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